9 results match your criteria: "Royal Brompton & Harefield Hospitals London[Affiliation]"
Intensive Care Med
August 2022
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy.
Intensive Care Med
June 2022
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy.
Purpose: To accommodate the unprecedented number of critically ill patients with pneumonia caused by coronavirus disease 2019 (COVID-19) expansion of the capacity of intensive care unit (ICU) to clinical areas not previously used for critical care was necessary. We describe the global burden of COVID-19 admissions and the clinical and organizational characteristics associated with outcomes in critically ill COVID-19 patients.
Methods: Multicenter, international, point prevalence study, including adult patients with SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) and a diagnosis of COVID-19 admitted to ICU between February 15th and May 15th, 2020.
Eur Respir J
October 2015
Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain
No current patient-centred instrument captures all dimensions of physical activity in chronic obstructive pulmonary disease (COPD). Our objective was item reduction and initial validation of two instruments to measure physical activity in COPD.Physical activity was assessed in a 6-week, randomised, two-way cross-over, multicentre study using PROactive draft questionnaires (daily and clinical visit versions) and two activity monitors.
View Article and Find Full Text PDFJ Thorac Oncol
September 2014
*Thoracic Surgery, University of Tokushima, Tokushima, Japan; †Thoracic Surgery, Antwerp University Hospital, Antwerp, Belgium; ‡Thoracic Surgery, Yale University, New Haven, CT; §Thoracic Surgery, Osaka University, Osaka, Japan; ‖Biostatistics, Cancer Research And Biostatistics, Seattle, WA; ¶Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan; #Radiation Oncology, Queen's University, Ontario, Canada; **Thoracic Surgery, University of Torino, Torino, Italy; ††Medical Oncology, Georgetown University, Washington, DC; ‡‡Thoracic Surgery, Sloan Kettering Cancer Center, New York, NY; §§Thoracic Surgery, Samsung Medical Center, Seoul, South Korea; ‖‖Thoracic Surgery, University of Pisa, Pisa, Italy; ¶¶Pathology, Regina Elena National Cancer Institute, Rome, Italy; ##Radiology, MD Anderson Cancer Center, Houston, TX; ***Pathology, Royal Brompton Hospital, London, UK.
Stage classification is an important underpinning of management of patients with cancer, and rests on a combination of three components: T for tumor extent, N for nodal involvement, and M for more distant metastases. This article details an initiative to develop proposals for the first official stage classification system for thymic malignancies for the 8th edition of the stage classification manuals. Specifically, the results of analysis of a large database and the considerations leading to the proposed N and M components are described.
View Article and Find Full Text PDFJ Thorac Oncol
September 2014
*Pathology, Royal Brompton Hospital, London, United Kingdom; †Thoracic Surgery, Yale University, New Haven, Connecticut; ‡Pathology, Regina Elena National Cancer Institute, Rome, Italy; §Thoracic Surgery, Samsung Medical Center, Seoul, South Korea; ‖Biostatistics, Cancer Research And Biostatistics, Seattle, Washington; ¶Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan; #Radiation Oncology, Queen's University, Ontario, Canada; **Thoracic Surgery, University of Torino, Torino, Italy; ††Medical Oncology, Georgetown University, Washington, District of Columbia; ‡‡Thoracic Surgery, Sloan Kettering Cancer Center, New York, New York; §§Thoracic Surgery, University of Tokushima, Tokushima, Japan; ‖‖Thoracic Surgery, University of Pisa, Pisa, Italy; ¶¶Radiology, MD Anderson Cancer Center, Houston, Texas; ##Thoracic Surgery, Osaka University, Osaka, Japan; and ***Thoracic Surgery, Antwerp University Hospital, Antwerp, Belgium.
Despite longstanding recognition of thymic epithelial neoplasms, there is no official American Joint Committee on Cancer/Union for International Cancer Control stage classification. This article summarizes proposals for classification of the T component of stage classification for use in the 8th edition of the tumor, node, metastasis classification for malignant tumors. This represents the output of the International Association for the Study of Lung Cancer and the International Thymic Malignancies Interest Group Staging and Prognostics Factor Committee, which assembled and analyzed a worldwide database of 10,808 patients with thymic malignancies from 105 sites.
View Article and Find Full Text PDFJ Thorac Oncol
September 2014
*Thoracic Surgery, Yale University, New Haven, CT; †Biostatistics, Cancer Research and Biostatistics, Seattle, WA; ‡Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan; §Radiation Oncology, Queen's University, Ontario, Canada; ‖Thoracic Surgery, University of Torino, Torino, Italy; ¶Medical Oncology, Georgetown University, Washington, DC; #Thoracic Surgery, Sloan Kettering Cancer Center, New York, NY; **Thoracic Surgery, Samsung Medical Center, Seoul, South Korea; ††Thoracic Surgery, University of Tokushima, Tokushima, Japan; ‡‡Thoracic Surgery, University of Pisa, Pisa, Italy; §§Pathology, Regina Elena National Cancer Institute, Rome, Italy; ‖‖Radiology, MD Anderson Cancer Center, Houston, TX; ¶¶Pathology, Royal Brompton Hospital, London, UK; ##Thoracic Surgery, Osaka University, Osaka, Japan; ***Thoracic Surgery, Antwerp University Hospital, Antwerp, Belgium; and ‖‖‖Thoracic Radiology, University of Maryland, Baltimore, Maryland.
A universal and consistent stage classification system, which describes the anatomic extent of a cancer, provides a foundation for communication and collaboration. Thymic epithelial malignancies have seen little progress, in part because of the lack of an official system. The International Association for the Study of Lung Cancer and the International Thymic Malignancies Interest Group assembled a large retrospective database, a multispecialty international committee and carried out extensive analysis to develop proposals for the 8th edition of the stage classification manuals.
View Article and Find Full Text PDFThorax
April 2014
Portex Unit: Respiratory Physiology and Medicine, UCL Institute of Child Health, , London, UK.
Rationale: Sensitive outcome measures applicable in different centres to quantify and track early pulmonary abnormalities in infants with cystic fibrosis (CF) are needed both for clinical care and interventional trials. Chest CT has been advocated as such a measure yet there is no validated scoring system in infants.
Objectives: The objectives of this study were to standardise CT data collection across multiple sites; ascertain the incidence of bronchial dilatation and air trapping in newborn screened (NBS) infants with CF at 1 year; and assess the reproducibility of Brody-II, the most widely used scoring system in children with CF, during infancy.
Eur Respir J
November 2013
Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh.
Symptoms during physical activity and physical inactivity are hallmarks of chronic obstructive pulmonary disease (COPD). Our aim was to evaluate the validity and usability of six activity monitors in patients with COPD against the doubly labelled water (DLW) indirect calorimetry method. 80 COPD patients (mean ± sd age 68 ± 6 years and forced expiratory volume in 1 s 57 ± 19% predicted) recruited in four centres each wore simultaneously three or four out of six commercially available monitors validated in chronic conditions for 14 consecutive days.
View Article and Find Full Text PDFNurs Manag (Harrow)
February 2006
Caroline Shuldham is director of nursing and quality at the Harefield NHS Trust, London.
DURING A CONVERSATION over dinner recently, I was asked what two things I would change in the health service. I found the question surprisingly difficult to answer but for the first I opted for making the NHS a safer place for patients, for staff and indeed for all involved.
View Article and Find Full Text PDF